211 related articles for article (PubMed ID: 34407845)
1. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
Morra A; Escala-Garcia M; Beesley J; Keeman R; Canisius S; Ahearn TU; Andrulis IL; Anton-Culver H; Arndt V; Auer PL; Augustinsson A; Beane Freeman LE; Becher H; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brenner H; Brüning T; Buys SS; Caan B; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Cheng TD; Clarke CL; ; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Dörk T; Dossus L; Dunning AM; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Eriksson M; Evans DG; Fasching PA; Flyger H; Fritschi L; Gago-Dominguez M; García-Sáenz JA; Giles GG; Grip M; Guénel P; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hart SN; Hartikainen JM; Hartmann A; He W; Hooning MJ; Hoppe R; Hopper JL; Howell A; Hunter DJ; ; ; Jager A; Jakubowska A; Janni W; John EM; Jung AY; Kaaks R; Keupers M; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kurian AW; Lacey JV; Lambrechts D; Le Marchand L; Lindblom A; Linet M; Luben RN; Lubiński J; Lush M; Mannermaa A; Manoochehri M; Margolin S; Martens JWM; Martinez ME; Mavroudis D; Michailidou K; Milne RL; Mulligan AM; Muranen TA; Nevanlinna H; Newman WG; Nielsen SF; Nordestgaard BG; Olshan AF; Olsson H; Orr N; Park-Simon TW; Patel AV; Peissel B; Peterlongo P; Plaseska-Karanfilska D; Prajzendanc K; Prentice R; Presneau N; Rack B; Rennert G; Rennert HS; Rhenius V; Romero A; Roylance R; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Smichkoska S; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Teras LR; Terry MB; Tollenaar RAEM; Tomlinson I; Troester MA; Truong T; Vachon CM; Wang Q; Hurson AN; Winqvist R; Wolk A; Ziogas A; Brauch H; García-Closas M; Pharoah PDP; Easton DF; Chenevix-Trench G; Schmidt MK
Breast Cancer Res; 2021 Aug; 23(1):86. PubMed ID: 34407845
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study of germline variants and breast cancer-specific mortality.
Escala-Garcia M; Guo Q; Dörk T; Canisius S; Keeman R; Dennis J; Beesley J; Lecarpentier J; Bolla MK; Wang Q; Abraham J; Andrulis IL; Anton-Culver H; Arndt V; Auer PL; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bernstein L; Blomqvist C; Boeckx B; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Brenner H; Brentnall A; Brinton L; Broberg P; Brock IW; Brucker SY; Burwinkel B; Caldas C; Caldés T; Campa D; Canzian F; Carracedo A; Carter BD; Castelao JE; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Cheng TD; Chin SF; Clarke CL; ; Cordina-Duverger E; Couch FJ; Cox DG; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dunn JA; Dunning AM; Durcan L; Dwek M; Earl HM; Ekici AB; Eliassen AH; Ellberg C; Engel C; Eriksson M; Evans DG; Figueroa J; Flesch-Janys D; Flyger H; Gabrielson M; Gago-Dominguez M; Galle E; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; George A; Georgoulias V; Giles GG; Glendon G; Goldgar DE; González-Neira A; Alnæs GIG; Grip M; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hankinson S; Harkness EF; Harrington PA; Hart SN; Hartikainen JM; Hein A; Hillemanns P; Hiller L; Holleczek B; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Howell A; Huang G; Humphreys K; Hunter DJ; Janni W; John EM; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kabisch M; Kaczmarek K; Kerin MJ; Khan S; Khusnutdinova E; Kiiski JI; Kitahara CM; Knight JA; Ko YD; Koppert LB; Kosma VM; Kraft P; Kristensen VN; Krüger U; Kühl T; Lambrechts D; Le Marchand L; Lee E; Lejbkowicz F; Li L; Lindblom A; Lindström S; Linet M; Lissowska J; Lo WY; Loibl S; Lubiński J; Lux MP; MacInnis RJ; Maierthaler M; Maishman T; Makalic E; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Mavroudis D; McLean C; Meindl A; Middha P; Miller N; Milne RL; Moreno F; Mulligan AM; Mulot C; Nassir R; Neuhausen SL; Newman WT; Nielsen SF; Nordestgaard BG; Norman A; Olsson H; Orr N; Pankratz VS; Park-Simon TW; Perez JIA; Pérez-Barrios C; Peterlongo P; Petridis C; Pinchev M; Prajzendanc K; Prentice R; Presneau N; Prokofieva D; Pylkäs K; Rack B; Radice P; Ramachandran D; Rennert G; Rennert HS; Rhenius V; Romero A; Roylance R; Saloustros E; Sawyer EJ; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schumacher F; Schwentner L; Scott RJ; Scott C; Seynaeve C; Shah M; Simard J; Smeets A; Sohn C; Southey MC; Swerdlow AJ; Talhouk A; Tamimi RM; Tapper WJ; Teixeira MR; Tengström M; Terry MB; Thöne K; Tollenaar RAEM; Tomlinson I; Torres D; Truong T; Turman C; Turnbull C; Ulmer HU; Untch M; Vachon C; van Asperen CJ; van den Ouweland AMW; van Veen EM; Wendt C; Whittemore AS; Willett W; Winqvist R; Wolk A; Yang XR; Zhang Y; Easton DF; Fasching PA; Nevanlinna H; Eccles DM; Pharoah PDP; Schmidt MK
Br J Cancer; 2019 Mar; 120(6):647-657. PubMed ID: 30787463
[TBL] [Abstract][Full Text] [Related]
3. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
Azzato EM; Tyrer J; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Arias JI; Menéndez P; Benítez J; Chang-Claude J; Hein R; Wang-Gohrke S; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kosma VM; Kataja V; ; Beesley J; Chen X; Chenevix-Trench G; Couch FJ; Olson JE; Fredericksen ZS; Wang X; Giles GG; Severi G; Baglietto L; Southey MC; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Lissowska J; Sherman ME; Bolton KL; Hall P; Czene K; Cox A; Brock IW; Elliott GC; Reed MW; Greenberg D; Anton-Culver H; Ziogas A; Humphreys M; Easton DF; Caporaso NE; Pharoah PD
J Natl Cancer Inst; 2010 May; 102(9):650-62. PubMed ID: 20308648
[TBL] [Abstract][Full Text] [Related]
4. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Lei J; Rudolph A; Moysich KB; Rafiq S; Behrens S; Goode EL; Pharoah PP; Seibold P; Fasching PA; Andrulis IL; Kristensen VN; Couch FJ; Hamann U; Hooning MJ; Nevanlinna H; Eilber U; Bolla MK; Dennis J; Wang Q; Lindblom A; Mannermaa A; Lambrechts D; García-Closas M; Hall P; Chenevix-Trench G; Shah M; Luben R; Haeberle L; Ekici AB; Beckmann MW; Knight JA; Glendon G; Tchatchou S; Alnæs GI; Borresen-Dale AL; Nord S; Olson JE; Hallberg E; Vachon C; Torres D; Ulmer HU; Rüdiger T; Jager A; van Deurzen CH; Tilanus-Linthorst MM; Muranen TA; Aittomäki K; Blomqvist C; Margolin S; Kosma VM; Hartikainen JM; Kataja V; Hatse S; Wildiers H; Smeets A; Figueroa J; Chanock SJ; Lissowska J; Li J; Humphreys K; Phillips KA; ; Linn S; Cornelissen S; van den Broek SA; Kang D; Choi JY; Park SK; Yoo KY; Hsiung CN; Wu PE; Hou MF; Shen CY; Teo SH; Taib NA; Yip CH; Ho GF; Matsuo K; Ito H; Iwata H; Tajima K; Dunning AM; Benitez J; Czene K; Sucheston LE; Maishman T; Tapper WJ; Eccles D; Easton DF; Schmidt MK; Chang-Claude J
Breast Cancer Res; 2015 Feb; 17(1):18. PubMed ID: 25849327
[TBL] [Abstract][Full Text] [Related]
5. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
[TBL] [Abstract][Full Text] [Related]
6. Common germline polymorphisms associated with breast cancer-specific survival.
Pirie A; Guo Q; Kraft P; Canisius S; Eccles DM; Rahman N; Nevanlinna H; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; van Ongeval C; Nordestgaard BG; Nielsen SF; Flyger H; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Olsen JE; Hallberg E; Vachon C; Knight JA; Glendon G; Mulligan AM; Broeks A; Cornelissen S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Butterbach K; Holleczek B; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Manoukian S; Ficarazzi F; Beckmann MW; Hein A; Ekici AB; Balleine R; Phillips KA; ; Benitez J; Zamora MP; Perez JI; Menéndez P; Jakubowska A; Lubinski J; Gronwald J; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; ; Evans DG; Abraham J; Earl H; Poole CJ; Hiller L; Dunn JA; Bowden S; Yang R; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson S; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; Garcia-Closas M; Couch FJ; Chenevix-Trench G; Mannermaa A; Andrulis IL; Hall P; Chang-Claude J; Easton DF; Bojesen SE; Cox A; Fasching PA; Pharoah PD; Schmidt MK
Breast Cancer Res; 2015 Apr; 17(1):58. PubMed ID: 25897948
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide association study of prognosis in breast cancer.
Azzato EM; Pharoah PD; Harrington P; Easton DF; Greenberg D; Caporaso NE; Chanock SJ; Hoover RN; Thomas G; Hunter DJ; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1140-3. PubMed ID: 20332263
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel genetic markers of breast cancer survival.
Guo Q; Schmidt MK; Kraft P; Canisius S; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Kar S; Beesley J; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Couch FJ; Olson JE; Vachon C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Broeks A; Hogervorst FB; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cox A; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Dieffenbach AK; Arndt V; Holleczek B; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Bonanni B; Mariani P; Fasching PA; Beckmann MW; Hein A; Ekici AB; Chenevix-Trench G; Balleine R; ; Phillips KA; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; Evans DG; Abraham JE; Earl HM; Hiller L; Dunn JA; Bowden S; Berg C; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson SE; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; García-Closas M; Hall P; Easton DF; Eccles DM; Rahman N; Nevanlinna H; Pharoah PD
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25890600
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189
[TBL] [Abstract][Full Text] [Related]
10. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
Escala-Garcia M; Canisius S; Keeman R; Beesley J; Anton-Culver H; Arndt V; Augustinsson A; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bojesen SE; Bolla MK; Brenner H; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Couch FJ; Czene K; Daly MB; Dennis J; Devilee P; Dörk T; Dunning AM; Easton DF; Ekici AB; Eliassen AH; Fasching PA; Flyger H; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Geisler J; Giles GG; Grip M; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hartikainen JM; Heemskerk-Gerritsen BAM; Hollestelle A; Hoppe R; Hopper JL; Hunter DJ; Jacot W; Jakubowska A; John EM; Jung AY; Kaaks R; Khusnutdinova E; Koppert LB; Kraft P; Kristensen VN; Kurian AW; Lambrechts D; Le Marchand L; Lindblom A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Margolin S; Mavroudis D; Muranen TA; Nevanlinna H; Olshan AF; Olsson H; Park-Simon TW; Patel AV; Peterlongo P; Pharoah PDP; Punie K; Radice P; Rennert G; Rennert HS; Romero A; Roylance R; Rüdiger T; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schoemaker MJ; Scott C; Southey MC; Surowy H; Swerdlow AJ; Tamimi RM; Teras LR; Thomas E; Tomlinson I; Troester MA; Vachon CM; Wang Q; Winqvist R; Wolk A; Ziogas A; ; Michailidou K; Chenevix-Trench G; Bachelot T; Schmidt MK
Sci Rep; 2021 Oct; 11(1):19787. PubMed ID: 34611289
[TBL] [Abstract][Full Text] [Related]
11. The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer.
Toomey S; Madden SF; Furney SJ; Fan Y; McCormack M; Stapleton C; Cremona M; Cavalleri GL; Milewska M; Elster N; Carr A; Fay J; Kay EW; Kennedy S; Crown J; Gallagher WM; Hennessy BT; Eustace AJ
Oncotarget; 2016 Nov; 7(46):75518-75525. PubMed ID: 27776352
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.
Seibold P; Schmezer P; Behrens S; Michailidou K; Bolla MK; Wang Q; Flesch-Janys D; Nevanlinna H; Fagerholm R; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Lambrechts D; Wildiers H; Kristensen V; Alnæs GG; Nord S; Borresen-Dale AL; Hooning MJ; Hollestelle A; Jager A; Seynaeve C; Li J; Liu J; Humphreys K; Dunning AM; Rhenius V; Shah M; Kabisch M; Torres D; Ulmer HU; Hamann U; Schildkraut JM; Purrington KS; Couch FJ; Hall P; Pharoah P; Easton DF; Schmidt MK; Chang-Claude J; Popanda O
BMC Cancer; 2015 Dec; 15():978. PubMed ID: 26674097
[TBL] [Abstract][Full Text] [Related]
14. An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
Zhu B; Mukherjee A; Machiela MJ; Song L; Hua X; Shi J; Garcia-Closas M; Chanock SJ; Chatterjee N
Br J Cancer; 2016 Sep; 115(6):752-60. PubMed ID: 27467053
[TBL] [Abstract][Full Text] [Related]
15. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
Figueroa JD; Garcia-Closas M; Humphreys M; Platte R; Hopper JL; Southey MC; Apicella C; Hammet F; Schmidt MK; Broeks A; Tollenaar RA; Van't Veer LJ; Fasching PA; Beckmann MW; Ekici AB; Strick R; Peto J; dos Santos Silva I; Fletcher O; Johnson N; Sawyer E; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Bojesen S; Flyger H; Nordestgaard BG; Benítez J; Milne RL; Ignacio Arias J; Zamora MP; Brenner H; Müller H; Arndt V; Rahman N; Turnbull C; Seal S; Renwick A; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Hein R; Wang-Gohrke S; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov YI; Karstens JH; Bermisheva M; Prokofieva D; Gantcev SH; Khusnutdinova E; Lindblom A; Margolin S; Chenevix-Trench G; Beesley J; Chen X; ; Mannermaa A; Kosma VM; Soini Y; Kataja V; Lambrechts D; Yesilyurt BT; Chrisiaens MR; Peeters S; Radice P; Peterlongo P; Manoukian S; Barile M; Couch F; Lee AM; Diasio R; Wang X; Giles GG; Severi G; Baglietto L; Maclean C; Offit K; Robson M; Joseph V; Gaudet M; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis I; Knight JA; Mulligan AM; O'Malley FP; Brinton LA; Sherman ME; Lissowska J; Chanock SJ; Hooning M; Martens JW; van den Ouweland AM; Collée JM; Hall P; Czene K; Cox A; Brock IW; Reed MW; Cross SS; Pharoah P; Dunning AM; Kang D; Yoo KY; Noh DY; Ahn SH; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Ding SL; Hsu HM; Yu JC; Anton-Culver H; Ziogas A; Ashworth A; Swerdlow A; Jones M; Orr N; Trentham-Dietz A; Egan K; Newcomb P; Titus-Ernstoff L; Easton D; Spurdle AB
Hum Mol Genet; 2011 Dec; 20(23):4693-706. PubMed ID: 21852249
[TBL] [Abstract][Full Text] [Related]
16. Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
Markkula A; Simonsson M; Rosendahl AH; Gaber A; Ingvar C; Rose C; Jernström H
Int J Cancer; 2014 Oct; 135(8):1898-910. PubMed ID: 24599585
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.
Schmidt MK; Tommiska J; Broeks A; van Leeuwen FE; Van't Veer LJ; Pharoah PD; Easton DF; Shah M; Humphreys M; Dörk T; Reincke SA; Fagerholm R; Blomqvist C; Nevanlinna H
Breast Cancer Res; 2009; 11(6):R89. PubMed ID: 20021639
[TBL] [Abstract][Full Text] [Related]
18. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
[TBL] [Abstract][Full Text] [Related]
19. Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.
Jamshidi M; Schmidt MK; Dörk T; Garcia-Closas M; Heikkinen T; Cornelissen S; van den Broek AJ; Schürmann P; Meyer A; Park-Simon TW; Figueroa J; Sherman M; Lissowska J; Keong GT; Irwanto A; Laakso M; Hautaniemi S; Aittomäki K; Blomqvist C; Liu J; Nevanlinna H
Int J Cancer; 2013 May; 132(9):2044-55. PubMed ID: 23034890
[TBL] [Abstract][Full Text] [Related]
20. Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
Larsen V; Barlow WE; Yang JJ; Zhu Q; Liu S; Kwan ML; Ergas IJ; Roh JM; Hutchins LF; Kadlubar SA; Albain KS; Rae JM; Yeh IT; Ravdin PM; Martino S; Lyss AP; Osborne CK; Hortobagyi GN; Kushi LH; Hayes DF; Ambrosone CB; Yao S
Clin Breast Cancer; 2019 Aug; 19(4):225-235.e2. PubMed ID: 30928413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
